ATE350664T1 - Screening nach antiviralen verbindungen, die die signalpeptidase beeinflussen - Google Patents

Screening nach antiviralen verbindungen, die die signalpeptidase beeinflussen

Info

Publication number
ATE350664T1
ATE350664T1 AT02772620T AT02772620T ATE350664T1 AT E350664 T1 ATE350664 T1 AT E350664T1 AT 02772620 T AT02772620 T AT 02772620T AT 02772620 T AT02772620 T AT 02772620T AT E350664 T1 ATE350664 T1 AT E350664T1
Authority
AT
Austria
Prior art keywords
agent
screening
components
component
signal peptide
Prior art date
Application number
AT02772620T
Other languages
English (en)
Inventor
J Mclauchlan
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of ATE350664T1 publication Critical patent/ATE350664T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
AT02772620T 2001-11-07 2002-11-07 Screening nach antiviralen verbindungen, die die signalpeptidase beeinflussen ATE350664T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0126782.2A GB0126782D0 (en) 2001-11-07 2001-11-07 Assay

Publications (1)

Publication Number Publication Date
ATE350664T1 true ATE350664T1 (de) 2007-01-15

Family

ID=9925363

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02772620T ATE350664T1 (de) 2001-11-07 2002-11-07 Screening nach antiviralen verbindungen, die die signalpeptidase beeinflussen

Country Status (7)

Country Link
US (1) US20050089839A1 (de)
EP (1) EP1444522B1 (de)
AT (1) ATE350664T1 (de)
AU (1) AU2002337378A1 (de)
DE (1) DE60217384T2 (de)
GB (1) GB0126782D0 (de)
WO (1) WO2003040684A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010030992A2 (en) * 2008-09-12 2010-03-18 The Board Of Trustees Of The University Of Illinois Novel plasmodium falciparum gene encoding signal peptide peptidase and methods of using inhibitors thereof for inhibiting malarial infection
US20210363214A1 (en) * 2018-03-01 2021-11-25 University Of Washington Transmembrane polypeptides

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221623A (en) * 1986-07-22 1993-06-22 Boyce Thompson Institute For Plant Research, Inc. Use of bacterial luciferase structural genes for cloning and monitoring gene expression in microorganisms and for tagging and identification of genetically engineered organisms
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
EP0992580B1 (de) * 1993-11-04 2005-03-09 Innogenetics N.V. Von menschlichen T-Zellen immunodominante Epitopen des Virus der C-Hepatitis
EP1076092A3 (de) * 1994-10-21 2001-03-28 Innogenetics N.V. Sequenzen von Hepatitis-C-Virus Typ 10, und dessen Verwendungen als vorbeugende. therapeutische und diagnostische Mitteln
WO2000043505A2 (de) * 1999-01-22 2000-07-27 Memorec Medical Molecular Research Cologne Stoffel Gmbh Protease mit zwei aspartatresten in der katalytisch aktiven struktur
DE19902550A1 (de) * 1999-01-22 2000-07-27 Memorec Medical Molecular Rese Aspartatprotease
WO2001021189A1 (en) * 1999-07-19 2001-03-29 Epimmune Inc. Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
CN1313399A (zh) * 2000-03-10 2001-09-19 上海博德基因开发有限公司 一种新的多肽——人信号肽酶15和编码这种多肽的多核苷酸
CN1315564A (zh) * 2000-03-28 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人信号肽酶10和编码这种多肽的多核苷酸

Also Published As

Publication number Publication date
GB0126782D0 (en) 2002-01-02
AU2002337378A1 (en) 2003-05-19
EP1444522B1 (de) 2007-01-03
WO2003040684A2 (en) 2003-05-15
DE60217384T2 (de) 2007-11-15
US20050089839A1 (en) 2005-04-28
DE60217384D1 (de) 2007-02-15
WO2003040684A3 (en) 2003-07-03
EP1444522A2 (de) 2004-08-11

Similar Documents

Publication Publication Date Title
EA199900388A1 (ru) Ингибиторы серин-протеаз, в частности ns3 протеазы вируса гепатита c (hvc)
IT1278077B1 (it) Metodologia per riprodurre in vitro le attivita' di rna polimerasi rna-dipendente e di nucleotidiltransferasi terminale codificate dal
ATE509120T1 (de) Fusionsproteine zur detektion von analyten
DK1409984T3 (da) Fremgangsmåder og reagenser til detektering af endotoxin
ATE417275T1 (de) Puffern zur stabilizierung von hcv antigenen
ATE231557T1 (de) Detektion des hepatis-c virus.
ATE552340T1 (de) Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismitteln
DK0484787T3 (da) HCV-specifikke peptider, fremgangsmåde til opnåelse deraf og anvendelse deraf
DE69723485D1 (de) Verfahren zur Identifizierung von Wirkstoffen gegen HCV durch Verwendung von Strukturkoordinaten der Hepatitis-C-Virus-Protease
DE69503759D1 (de) Verfahren zur erkennung von dienstwechselwirkungen in intelligenten netzwerken
ATE303597T1 (de) Hcv mosaik antigen zusammensetzung
DE60216445D1 (de) Universelles nachweissystem für mehrere varianten
DE60118621D1 (de) Verfahren zur bestimmung der nitrosylierung von proteinen
NZ508724A (en) Analytical method using at least two viruses to detect a target material in a sample
ATE350664T1 (de) Screening nach antiviralen verbindungen, die die signalpeptidase beeinflussen
DE69013471D1 (de) Methode zur Stabilisierung von rekombinanten Hepatitis-B-Virus-Oberflächenproteinen aus Hefe.
DE50206549D1 (de) Auswerteschaltung und Signalverarbeitungsverfahren
EP1878797A3 (de) Antigene Peptide zur Gruppierung des Hepatitis-C-Virus, Kit damit und Verfahren zur Gruppierung unter Verwendung dieses Kits
DK0491713T3 (da) Rubella El-peptider og C-peptider
WO2002060924A3 (en) Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
ATE323184T1 (de) Verfahren zur herstellung von blutplasmaprodukten durch ausschluss von spenden mit hohen parvo-b19- virenkonzentrationen
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ATE199596T1 (de) Diagnostisches reagenz für hepatitis c
DK1417233T3 (da) Humant rekombinant antistof mod det hepatitis C (HCV) ikke-strukturelle NS3-protein, nukleinsyre og anvendelser deraf
FI952778A (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties